• Register
  • Login
  • Subscribe
  • Contact Us

Acquisition of Oncologico Medicima Affatinib 40 Mg for Incan and Other Oncological Centers Dependent on the Ministry of Public Health and B.s.

ParaguayTenders notice for Acquisition of Oncologico Medicima Affatinib 40 Mg for Incan and Other Oncological Centers Dependent on the Ministry of Public Health and B.s.. The reference ID of the tender is 85291248 and it is closing on 19 Jul 2023.

Tender Details

  • Country: Paraguay
  • Summary: Acquisition of Oncologico Medicima Affatinib 40 Mg for Incan and Other Oncological Centers Dependent on the Ministry of Public Health and B.s.
  • PYT Ref No: 85291248
  • Deadline: 19 Jul 2023
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 430185
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Oncologico Affatinib 40 mg acquisition for INCAN and other oncological centers dependent on the Ministry of Public Health and B.S.
    Call data -
    SPECIAL CHARACTERISTICS PLURIANUAL OPEN CONTRACT Auction Electronic Pliego
    Bidding ID: 430185
    Bidding name: Acquisition of Oncologico Medicima Affatinib 40 mg for INCAN and other oncological centers dependent on the Ministry of Public Health and B.S.
    Convocant: National Cancer Institute / Ministry of Public Health and Social Welfare
    Category: 17 - Teams, products and medical and laboratory instruments. Health care services
    Hiring Unit: National Cancer Institute
    Type of procedure: LPN - National Public Tender
    Estimated amount: ₲ 6,054,048,000:
    Offers maintenance guarantee percentage: 5%
    Type of guarantee: policy or bank guarantee ::
    State: In Call (open)
    Publication date: 05-07-2023-12:34
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Acquisition of Oncologico Medicima Affatinib 40 Mg for Incan and Other Oncological Centers Dependent on the Ministry of Public Health and B.s. - Paraguay Tender

The NATIONAL CANCER INSTITUTE, a Government sector organization in Paraguay, has announced a new tender for Acquisition of Oncologico Medicima Affatinib 40 Mg for Incan and Other Oncological Centers Dependent on the Ministry of Public Health and B.s.. This tender is published on ParaguayTenders under PYT Ref No: 85291248 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-07-19.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

ParaguayTenders Features

ParaguayTenders Features

Fresh and verified Tenders from Paraguay. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ParaguayTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Paraguay in your email inbox.

  Chat with us